CV Sciences, Inc. Announces New Distribution With Kroger and Expands Its Offering of Topical Products
12 juin 2019 12h00 HE
|
CV Sciences, Inc.
PlusCBD™ Oil Roll-On Launch at 945 Kroger Stores in 17 U.S. States LAS VEGAS, June 12, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a...
CV Sciences Comments on FDA CBD Hearing
06 juin 2019 16h27 HE
|
CV Sciences, Inc.
Top hemp CBD Company urges FDA to swiftly develop regulations to separate an agricultural commodity from a controlled substance and ensure consumer safety LAS VEGAS, June 06, 2019 (GLOBE NEWSWIRE)...
CV Sciences, Inc. Applauds California Assembly Support of Hemp-derived CBD products through Unanimous Passing of AB 228
22 mai 2019 08h45 HE
|
CV Sciences, Inc.
CBD Legislation clears major hurdle in California Legislature LAS VEGAS, May 22, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “”, “our”, “us” or “we”), a preeminent...
CV Sciences’ PlusCBD Oil™ Used in First Study Examining Clinical Benefit of CBD for Patients with PTSD
14 mai 2019 08h45 HE
|
CV Sciences, Inc.
Study Finds CBD Associated with PTSD Symptom Reduction in Adults with PTSD LAS VEGAS, May 14, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or...
CV Sciences, Inc. Reports First Quarter 2019 Financial Results
08 mai 2019 16h05 HE
|
CV Sciences, Inc.
Record quarterly revenue Increased retail distribution by over 1,000 stores LAS VEGAS, May 08, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) ("CV Sciences" or the “Company”) announced...
CV Sciences, Inc. to Present at Upcoming Investor Conferences
07 mai 2019 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, May 07, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products through its...
CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2019
30 avr. 2019 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its first...
CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor
15 avr. 2019 16h00 HE
|
CV Sciences, Inc.
LAS VEGAS, April 15, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products,...
CV Sciences, Inc. Announces Distribution Expansion Into Food, Drug and Mass Channels
10 avr. 2019 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, April 10, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products, is...
CV Sciences, Inc. Appoints Joerg Grasser as New Chief Financial Officer
21 mars 2019 17h00 HE
|
CV Sciences, Inc.
LAS VEGAS, March 21, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products through...